Ihuman Non Current Assets Total from 2010 to 2024
| IH Stock | USD 2.00 0.01 0.50% |
Non Current Assets Total | First Reported 2010-12-31 | Previous Quarter 68.1 M | Current Value 48.6 M | Quarterly Volatility 32 M |
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 34.8 M, Depreciation And Amortization of 6 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0117 or PTB Ratio of 1.34. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
Ihuman | Non Current Assets Total |
Latest Ihuman's Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of Ihuman Inc over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Ihuman's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
| Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
| Timeline |
Ihuman Non Current Assets Total Regression Statistics
| Arithmetic Mean | 21,609,714 | |
| Geometric Mean | 4,955,788 | |
| Coefficient Of Variation | 148.18 | |
| Mean Deviation | 26,583,753 | |
| Median | 1,274,000 | |
| Standard Deviation | 32,022,028 | |
| Sample Variance | 1025.4T | |
| Range | 84.4M | |
| R-Value | 0.77 | |
| Mean Square Error | 451.1T | |
| R-Squared | 0.59 | |
| Significance | 0.0008 | |
| Slope | 5,507,054 | |
| Total Sum of Squares | 14355.7T |
Ihuman Non Current Assets Total History
About Ihuman Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ihuman income statement, its balance sheet, and the statement of cash flows. Ihuman investors use historical funamental indicators, such as Ihuman's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Ihuman investors may use each financial statement separately, they are all related. The changes in Ihuman's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ihuman's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ihuman Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ihuman. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Assets Total | 68.1 M | 48.6 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Ihuman Stock
When determining whether Ihuman Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ihuman's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ihuman Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ihuman Inc Stock:Check out the analysis of Ihuman Correlation against competitors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Earnings Share 0.46 | Revenue Per Share 19.279 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0718 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.